Andrey Sivachenko
Overview
Explore the profile of Andrey Sivachenko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
32282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bihler H, Sivachenko A, Millen L, Bhatt P, Patel A, Chin J, et al.
J Cyst Fibros
. 2024 Feb;
23(4):664-675.
PMID: 38388235
Background: In 2017, the US Food and Drug Administration initiated expansion of drug labels for the treatment of cystic fibrosis (CF) to include CF transmembrane conductance regulator (CFTR) gene variants...
2.
Valley H, Bukis K, Bell A, Cheng Y, Wong E, Jordan N, et al.
J Cyst Fibros
. 2018 Dec;
18(4):476-483.
PMID: 30563749
Background: Assessment of approved drugs and developmental drug candidates for rare cystic fibrosis (CF)-causing variants of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) requires abundant material from relevant models. Methods:...
3.
Perry J, Kiezun A, Tonzi P, Van Allen E, Carter S, Baca S, et al.
Proc Natl Acad Sci U S A
. 2014 Dec;
111(51):E5564-73.
PMID: 25512523
Osteosarcoma is the most common primary bone tumor, yet there have been no substantial advances in treatment or survival in three decades. We examined 59 tumor/normal pairs by whole-exome, whole-genome,...
4.
Crompton B, Stewart C, Taylor-Weiner A, Alexe G, Kurek K, Calicchio M, et al.
Cancer Discov
. 2014 Sep;
4(11):1326-41.
PMID: 25186949
Unlabelled: Pediatric Ewing sarcoma is characterized by the expression of chimeric fusions of EWS and ETS family transcription factors, representing a paradigm for studying cancers driven by transcription factor rearrangements....
5.
Van Allen E, Wagle N, Stojanov P, Perrin D, Cibulskis K, Marlow S, et al.
Nat Med
. 2014 May;
20(6):682-8.
PMID: 24836576
Translating whole-exome sequencing (WES) for prospective clinical use may have an impact on the care of patients with cancer; however, multiple innovations are necessary for clinical implementation. These include rapid...
6.
Miranda K, Bond D, Levin J, Adiconis X, Sivachenko A, Russ C, et al.
PLoS One
. 2014 May;
9(5):e96094.
PMID: 24816817
Intact RNA from exosomes/microvesicles (collectively referred to as microvesicles) has sparked much interest as potential biomarkers for the non-invasive analysis of disease. Here we use the Illumina Genome Analyzer to...
7.
Torres-Garcia W, Zheng S, Sivachenko A, Vegesna R, Wang Q, Yao R, et al.
Bioinformatics
. 2014 Apr;
30(15):2224-6.
PMID: 24695405
Summary: Technological advances in high-throughput sequencing necessitate improved computational tools for processing and analyzing large-scale datasets in a systematic automated manner. For that purpose, we have developed PRADA (Pipeline for...
8.
Brooks A, Choi P, de Waal L, Sharifnia T, Imielinski M, Saksena G, et al.
PLoS One
. 2014 Feb;
9(1):e87361.
PMID: 24498085
Although recurrent somatic mutations in the splicing factor U2AF1 (also known as U2AF35) have been identified in multiple cancer types, the effects of these mutations on the cancer transcriptome have...
9.
Francis J, Kiezun A, Ramos A, Serra S, Pedamallu C, Qian Z, et al.
Nat Genet
. 2013 Nov;
45(12):1483-6.
PMID: 24185511
The diagnosed incidence of small intestine neuroendocrine tumors (SI-NETs) is increasing, and the underlying genomic mechanisms have not yet been defined. Using exome- and genome-sequence analysis of SI-NETs, we identified...
10.
Liao R, Jung J, Tchaicha J, Wilkerson M, Sivachenko A, Beauchamp E, et al.
Cancer Res
. 2013 Jun;
73(16):5195-205.
PMID: 23786770
A comprehensive description of genomic alterations in lung squamous cell carcinoma (lung SCC) has recently been reported, enabling the identification of genomic events that contribute to the oncogenesis of this...